ready to use do 7 Search Results


90
Biogenex monoclonal mouse igg2b antibody do7
Monoclonal Mouse Igg2b Antibody Do7, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/primary+mouse+monoclonal+antibody+against+p53+protein/pmc04818835-74-9-14
Average 90 stars, based on 1 article reviews
monoclonal mouse igg2b antibody do7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Novocastra anti-p53 monoclonal antibody novocastra clone do-7
Anti P53 Monoclonal Antibody Novocastra Clone Do 7, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/p53+antibody/pm26163638-66-7-10
Average 90 stars, based on 1 article reviews
anti-p53 monoclonal antibody novocastra clone do-7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

p53  (OriGene)
94
OriGene p53
Representative histopathological features of pseudomyxoma peritonei: histological morphology of low-grade mucinous carcinoma (LGMC) (a), high-grade mucinous carcinoma (HGMC) (b) and high-grade with signet ring cells (HGMC-S) (c) (all haematoxylin and eosin; scale bar 50 µm); strong positive staining for carcinoembryonic antigen in LGMC (d), HGMC (e) and HGMC-S (f); weak focal nuclear staining of <t>p53</t> in LGMC (g); complete lack of stained tumour nuclei for p53 in HGMC (h); strong positive staining for p53 in HGMC-S (i); low Ki67 LI in LGMC (j); high Ki67 LI in HGMC (k) and HGMC-S (l) (d–l, EnVision staining; scale bar 50 µm). The colour version of this figure is available at: http://imr.sagepub.com .
P53, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/p53+(TP53)+Mouse+Monoclonal+Antibody/pmc08492452-87-20-26
Average 94 stars, based on 1 article reviews
p53 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Nichirei Corporation p53 do-7 antibody
Representative histopathological features of pseudomyxoma peritonei: histological morphology of low-grade mucinous carcinoma (LGMC) (a), high-grade mucinous carcinoma (HGMC) (b) and high-grade with signet ring cells (HGMC-S) (c) (all haematoxylin and eosin; scale bar 50 µm); strong positive staining for carcinoembryonic antigen in LGMC (d), HGMC (e) and HGMC-S (f); weak focal nuclear staining of <t>p53</t> in LGMC (g); complete lack of stained tumour nuclei for p53 in HGMC (h); strong positive staining for p53 in HGMC-S (i); low Ki67 LI in LGMC (j); high Ki67 LI in HGMC (k) and HGMC-S (l) (d–l, EnVision staining; scale bar 50 µm). The colour version of this figure is available at: http://imr.sagepub.com .
P53 Do 7 Antibody, supplied by Nichirei Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/p53+do+7+antibody/pm37370880-48-9-17
Average 90 stars, based on 1 article reviews
p53 do-7 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biogenex anti-p53 protein primary monoclonal mouse antibody
Representative histopathological features of pseudomyxoma peritonei: histological morphology of low-grade mucinous carcinoma (LGMC) (a), high-grade mucinous carcinoma (HGMC) (b) and high-grade with signet ring cells (HGMC-S) (c) (all haematoxylin and eosin; scale bar 50 µm); strong positive staining for carcinoembryonic antigen in LGMC (d), HGMC (e) and HGMC-S (f); weak focal nuclear staining of <t>p53</t> in LGMC (g); complete lack of stained tumour nuclei for p53 in HGMC (h); strong positive staining for p53 in HGMC-S (i); low Ki67 LI in LGMC (j); high Ki67 LI in HGMC (k) and HGMC-S (l) (d–l, EnVision staining; scale bar 50 µm). The colour version of this figure is available at: http://imr.sagepub.com .
Anti P53 Protein Primary Monoclonal Mouse Antibody, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/p53+antibody/pmc05483674-86-41-49
Average 90 stars, based on 1 article reviews
anti-p53 protein primary monoclonal mouse antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ZSGB Biotech primary mouse monoclonal anti-p53 (mutant) antibody clone do-7
Immunohistology. (A) The differential expression of <t>P53</t> among different small sampling blocks in the same multi-site sampling block. (B) The differential expression of Ki67 among different small sampling blocks in the same multi-site sampling block. (C) The differential expression of CyclinD1 among different small sampling blocks in the same multi-site sampling block. (D) The positive detection rate of two methods. (E) The average positive rate of two methods.
Primary Mouse Monoclonal Anti P53 (Mutant) Antibody Clone Do 7, supplied by ZSGB Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/p53+zm+0408+antibody/pmc08141800-70-7-15
Average 90 stars, based on 1 article reviews
primary mouse monoclonal anti-p53 (mutant) antibody clone do-7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bio SB Inc mouse anti-human p53 bsb5842
Immunohistochemical protein expression of <t>p53</t> (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.
Mouse Anti Human P53 Bsb5842, supplied by Bio SB Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/mouse+anti+human+p53+bsb5842/pmc09994657-55-16-6
Average 90 stars, based on 1 article reviews
mouse anti-human p53 bsb5842 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Novocastra ncl l p53 do7
Immunohistochemical protein expression of <t>p53</t> (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.
Ncl L P53 Do7, supplied by Novocastra, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/anti+p53/pmc13278678-3-6-4
Average 86 stars, based on 1 article reviews
ncl l p53 do7 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Novocastra do-7 antibody
Immunohistochemical protein expression of <t>p53</t> (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.
Do 7 Antibody, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/do+7+antibody/pmc08057648-10-2-3
Average 90 stars, based on 1 article reviews
do-7 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cell Marque do-7 (cell marque, rockin, ca) antibody
Immunohistochemical protein expression of <t>p53</t> (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.
Do 7 (Cell Marque, Rockin, Ca) Antibody, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/do+7++cell+marque++rockin++ca++antibody/pmc04858134-115-34-35
Average 90 stars, based on 1 article reviews
do-7 (cell marque, rockin, ca) antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson p53 (do-7
Immunohistochemical protein expression of <t>p53</t> (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.
P53 (Do 7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ready+to+use+do+7/anti+p53/10__1158_slash_0008___5472__can___08___1377-79-20-23
Average 90 stars, based on 1 article reviews
p53 (do-7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Representative histopathological features of pseudomyxoma peritonei: histological morphology of low-grade mucinous carcinoma (LGMC) (a), high-grade mucinous carcinoma (HGMC) (b) and high-grade with signet ring cells (HGMC-S) (c) (all haematoxylin and eosin; scale bar 50 µm); strong positive staining for carcinoembryonic antigen in LGMC (d), HGMC (e) and HGMC-S (f); weak focal nuclear staining of p53 in LGMC (g); complete lack of stained tumour nuclei for p53 in HGMC (h); strong positive staining for p53 in HGMC-S (i); low Ki67 LI in LGMC (j); high Ki67 LI in HGMC (k) and HGMC-S (l) (d–l, EnVision staining; scale bar 50 µm). The colour version of this figure is available at: http://imr.sagepub.com .

Journal: The Journal of International Medical Research

Article Title: Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin

doi: 10.1177/03000605211022297

Figure Lengend Snippet: Representative histopathological features of pseudomyxoma peritonei: histological morphology of low-grade mucinous carcinoma (LGMC) (a), high-grade mucinous carcinoma (HGMC) (b) and high-grade with signet ring cells (HGMC-S) (c) (all haematoxylin and eosin; scale bar 50 µm); strong positive staining for carcinoembryonic antigen in LGMC (d), HGMC (e) and HGMC-S (f); weak focal nuclear staining of p53 in LGMC (g); complete lack of stained tumour nuclei for p53 in HGMC (h); strong positive staining for p53 in HGMC-S (i); low Ki67 LI in LGMC (j); high Ki67 LI in HGMC (k) and HGMC-S (l) (d–l, EnVision staining; scale bar 50 µm). The colour version of this figure is available at: http://imr.sagepub.com .

Article Snippet: Immunohistochemical staining was performed using primary mouse monoclonal antibodies against Ki67 (clone UMAB107 ready to use; OriGene China, Beijing, China), p53 (clone DO7 ready to use; OriGene China) and CEA (clone COL1 ready to use; OriGene China) that were processed in automated staining equipment (INTELLIPATH FLX®; Biocare Medical, Pacheco, CA, USA).

Techniques: Staining

Kaplan–Meier survival curves of patients with pseudomyxoma peritonei stratified according to the following: (a) histological grade; (b) Ki67 immunostaining; (c) p53 status; (d) Ki67 and p53 subgroups. The colour version of this figure is available at: http://imr.sagepub.com .

Journal: The Journal of International Medical Research

Article Title: Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin

doi: 10.1177/03000605211022297

Figure Lengend Snippet: Kaplan–Meier survival curves of patients with pseudomyxoma peritonei stratified according to the following: (a) histological grade; (b) Ki67 immunostaining; (c) p53 status; (d) Ki67 and p53 subgroups. The colour version of this figure is available at: http://imr.sagepub.com .

Article Snippet: Immunohistochemical staining was performed using primary mouse monoclonal antibodies against Ki67 (clone UMAB107 ready to use; OriGene China, Beijing, China), p53 (clone DO7 ready to use; OriGene China) and CEA (clone COL1 ready to use; OriGene China) that were processed in automated staining equipment (INTELLIPATH FLX®; Biocare Medical, Pacheco, CA, USA).

Techniques: Immunostaining

Univariate analysis of overall survival of patients ( n = 141) with pseudomyxoma peritonei.

Journal: The Journal of International Medical Research

Article Title: Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin

doi: 10.1177/03000605211022297

Figure Lengend Snippet: Univariate analysis of overall survival of patients ( n = 141) with pseudomyxoma peritonei.

Article Snippet: Immunohistochemical staining was performed using primary mouse monoclonal antibodies against Ki67 (clone UMAB107 ready to use; OriGene China, Beijing, China), p53 (clone DO7 ready to use; OriGene China) and CEA (clone COL1 ready to use; OriGene China) that were processed in automated staining equipment (INTELLIPATH FLX®; Biocare Medical, Pacheco, CA, USA).

Techniques:

The difference in clinicopathological characteristics between patients ( n = 141) with pseudomyxoma peritonei stratified according to Ki67 and  p53  immunostaining levels.

Journal: The Journal of International Medical Research

Article Title: Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin

doi: 10.1177/03000605211022297

Figure Lengend Snippet: The difference in clinicopathological characteristics between patients ( n = 141) with pseudomyxoma peritonei stratified according to Ki67 and p53 immunostaining levels.

Article Snippet: Immunohistochemical staining was performed using primary mouse monoclonal antibodies against Ki67 (clone UMAB107 ready to use; OriGene China, Beijing, China), p53 (clone DO7 ready to use; OriGene China) and CEA (clone COL1 ready to use; OriGene China) that were processed in automated staining equipment (INTELLIPATH FLX®; Biocare Medical, Pacheco, CA, USA).

Techniques: Immunostaining

Multivariate analysis of the association between  Ki67/p53  status and the overall survival of patients ( n = 141) with pseudomyxoma peritonei.

Journal: The Journal of International Medical Research

Article Title: Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin

doi: 10.1177/03000605211022297

Figure Lengend Snippet: Multivariate analysis of the association between Ki67/p53 status and the overall survival of patients ( n = 141) with pseudomyxoma peritonei.

Article Snippet: Immunohistochemical staining was performed using primary mouse monoclonal antibodies against Ki67 (clone UMAB107 ready to use; OriGene China, Beijing, China), p53 (clone DO7 ready to use; OriGene China) and CEA (clone COL1 ready to use; OriGene China) that were processed in automated staining equipment (INTELLIPATH FLX®; Biocare Medical, Pacheco, CA, USA).

Techniques:

Immunohistology. (A) The differential expression of P53 among different small sampling blocks in the same multi-site sampling block. (B) The differential expression of Ki67 among different small sampling blocks in the same multi-site sampling block. (C) The differential expression of CyclinD1 among different small sampling blocks in the same multi-site sampling block. (D) The positive detection rate of two methods. (E) The average positive rate of two methods.

Journal: Frontiers in Medicine

Article Title: Multi-Site Tumour Sampling Improves the Detection of Intra-Tumour Heterogeneity in Oral and Oropharyngeal Squamous Cell Carcinoma

doi: 10.3389/fmed.2021.670305

Figure Lengend Snippet: Immunohistology. (A) The differential expression of P53 among different small sampling blocks in the same multi-site sampling block. (B) The differential expression of Ki67 among different small sampling blocks in the same multi-site sampling block. (C) The differential expression of CyclinD1 among different small sampling blocks in the same multi-site sampling block. (D) The positive detection rate of two methods. (E) The average positive rate of two methods.

Article Snippet: Tissue sections were incubated with a ready-to-use primary mouse monoclonal anti-p53 (mutant) antibody (clone DO-7, ZSGB-BIO), mouse monoclonal anti-Ki67 antibody (clone GM-001, Gene Tech), and rabbit monoclonal anti-cyclin D1 antibody (clone EP12, ZSGB-BIO), according to the manufacturers' instructions.

Techniques: Quantitative Proteomics, Sampling, Blocking Assay

Immunohistochemical protein expression of p53 (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.

Journal: Journal of Clinical and Experimental Dentistry

Article Title: Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts

doi: 10.4317/jced.59769

Figure Lengend Snippet: Immunohistochemical protein expression of p53 (400x). (A) conventonal ameloblastoma; (B) luminal unicystic UA; (C) intraluminal UA; (D) mural UA; (E), OKC non-syndromic or sporadic; (F), OKC related NBSCC; (G), EPC: oral squamous cell carcinoma; (H), ENC: oral squamous cell carcinoma. Abbreviations: UA: unicystic ameloblastoma; EPC: external positive control; ENC: external negative control; OKC: odontogenic keratocyst; NBSCC: naevoid basal cell carcinoma syndrome.

Article Snippet: Primary monoclonal antibodies ( ) from Bio SB Inc. were incubated overnight at 4 °C for mouse anti-human P53 (BSB5842, clone: DO7, Ready-To-Use); mouse anti-human Bcl-2 (BSB5075, clone: BCL2/A4, Concentrated), and rabbit anti-human Bax (BSB6079, clone: E63, Ready-To-Use).

Techniques: Immunohistochemical staining, Expressing, Positive Control, Negative Control